Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment

<p>Secondary Antibody Information</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Jonathan M.J. Derry (16648337) (author)
Altres autors:	Connor Burns (16648340) (author), Jason P. Frazier (16648343) (author), Emily Beirne (16648346) (author), Marc Grenley (16648349) (author), Christopher C. DuFort (16648352) (author), Emily Killingbeck (16648355) (author), Michael Leon (16648358) (author), Claire Williams (16648361) (author), Mark Gregory (16648364) (author), Jeffrey Houlton (16648367) (author), Daniel Clayburgh (16648370) (author), Paul Swiecicki (16648373) (author), Dennis Huszar (16648376) (author), Allison Berger (15134507) (author), Richard A. Klinghoffer (16648379) (author)
Publicat:	2025
Matèries:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Immuno-oncology Methods and Technology Drug Discovery Technologies Novel assay technology Gene Regulation Posttranscriptional and translational control Head, Neck & Oral Cancers Immunology Immunomodulation Innate immunity Tumor-associated macrophages Translational Research Tumor Microenvironment Immune cells and the microenvironment
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Suppl video 4 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Supplementary Table 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Table S9 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
per: Zhihang Chen (17315678)
Publicat: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
per: Erika Y. Faraoni (14844897)
Publicat: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
per: Erika Y. Faraoni (14844897)
Publicat: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
per: Erika Y. Faraoni (14844897)
Publicat: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
per: Yu Chen (1234761)
Publicat: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
per: Yu Chen (1234761)
Publicat: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
per: Yu Chen (1234761)
Publicat: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
per: Yu Chen (1234761)
Publicat: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
per: Anuja Sathe (15028097)
Publicat: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
per: Min Wu (14962986)
Publicat: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
per: Min Wu (14962986)
Publicat: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
per: Min Wu (14962986)
Publicat: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
per: Min Wu (14962986)
Publicat: (2025)

Figure 1 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Figure 2 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Figure 3 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Figure 4 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Figure 5 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Figure 6 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Figure 7 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Supplementary Table S1 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Supplementary Table S2 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Supplementary Table S3 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Supplementary Table S4 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
per: Ernesto Gargiulo (15134961)
Publicat: (2025)

Table S1 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
per: Hanyun Zhang (15386757)
Publicat: (2025)

Table S2 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
per: Hanyun Zhang (15386757)
Publicat: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
per: Kankan Cao (16437263)
Publicat: (2025)

Supplementary Figures SF1-SF9 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
per: Robin M. Hallett (15037427)
Publicat: (2025)

Supplementary Tables ST1-ST6 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
per: Robin M. Hallett (15037427)
Publicat: (2025)

Cannot write session to /tmp/vufind_sessions/sess_6gohevcldu70tdflq2ie815ls2